wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34788381-90BA52A7-F206-45C2-9FF0-CBAA0F82840E
Q34788381-90BA52A7-F206-45C2-9FF0-CBAA0F82840E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34788381-90BA52A7-F206-45C2-9FF0-CBAA0F82840E
Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.
P2860
Q34788381-90BA52A7-F206-45C2-9FF0-CBAA0F82840E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34788381-90BA52A7-F206-45C2-9FF0-CBAA0F82840E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be5785cf000da412af12f9d614db0992be06798d
P2860
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma.